Literature DB >> 8012503

Expression of the cholecystokinin precursor gene in rat tissues.

A Funakoshi1, A Tanaka, T Kawanami, K Tateishi, K Miyasaka, A Kono.   

Abstract

Cholecystokinin, a brain gut peptide that stimulates gall bladder contraction and pancreatic exocrine secretion, also acts as a neurotransmitter. In this study, we demonstrated that small amounts of cholecystokinin precursor mRNA were expressed in the heart, lung, and kidney, as well as in the brain and the small intestine. The nucleotide sequences of the coding regions of the cholecystokinin precursor mRNA in these tissues were identical to those of the small intestine, indicating that cholecystokinin precursor proteins produced in these tissues are identical to those in small intestine. This is the first report demonstrating that the cholecystokinin precursor gene is expressed in the heart, lung, and kidney, as well as in the gastrointestinal tract and brain.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 8012503     DOI: 10.1007/bf02358672

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  8 in total

1.  Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction.

Authors:  P Chomczynski; N Sacchi
Journal:  Anal Biochem       Date:  1987-04       Impact factor: 3.365

2.  Nucleotide sequence of rat beta 2-microglobulin cDNA.

Authors:  F Mauxion; M Kress
Journal:  Nucleic Acids Res       Date:  1987-09-25       Impact factor: 16.971

3.  Cloning and sequence analysis of a cDNA encoding rat preprocholecystokinin.

Authors:  R J Deschenes; L J Lorenz; R S Haun; B A Roos; K J Collier; J E Dixon
Journal:  Proc Natl Acad Sci U S A       Date:  1984-02       Impact factor: 11.205

4.  Immunochemical evidence of cholecystokinin-like peptides in brain.

Authors:  G J Dockray
Journal:  Nature       Date:  1976-12-09       Impact factor: 49.962

5.  Absence of luminal bile increases duodenal content of cholecystokinin in rats.

Authors:  K Miyasaka; A Funakoshi; M Matsumoto; A Jimi; F Shikado; K Kitani
Journal:  Proc Soc Exp Biol Med       Date:  1991-06

6.  High plasma cholecystokinin levels in patients with chronic pancreatitis having abdominal pain.

Authors:  A Funakoshi; I Nakano; H Shinozaki; K Tateishi; T Hamaoka; H Ibayashi
Journal:  Am J Gastroenterol       Date:  1986-12       Impact factor: 10.864

7.  Transcription of the dystrophin gene in human muscle and non-muscle tissue.

Authors:  J Chelly; J C Kaplan; P Maire; S Gautron; A Kahn
Journal:  Nature       Date:  1988-06-30       Impact factor: 49.962

8.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

  8 in total
  4 in total

1.  Effects of intraduodenal administration of a low dose of cholecystokinin (CCK) antagonist (CR-1505) on plasma CCK concentration, intestinal CCK content, and levels of CCK mRNA.

Authors:  N Sazaki; K Miyasaka; M Matsumoto; A Funakoshi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

2.  Changes in gene expression of cholecystokinin-A receptor after induction of pancreatitis by pancreatic duct occlusion in rats.

Authors:  K Miyasaka; A Funakoshi
Journal:  J Gastroenterol       Date:  1995-10       Impact factor: 7.527

3.  Effect of a new cholecystokinin antagonist (FK 480) on gene expression of cholecystokinin and secretin in rat intestine.

Authors:  A Funakoshi; K Miyasaka
Journal:  J Gastroenterol       Date:  1994-06       Impact factor: 7.527

4.  Cholecystokinin Expression in the Development of Myocardial Hypertrophy.

Authors:  Zhongshu Han; Sheng Bi; Yongsheng Xu; Xiaoying Dong; Lixia Mei; Hailong Lin; Xueqi Li
Journal:  Scanning       Date:  2021-08-21       Impact factor: 1.932

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.